Synopsis of recent research by authors named "Sanjay Hake"
- Sanjay Hake's research primarily focuses on clinical trials and therapeutic interventions, particularly in the field of psychiatry, as evidenced by his work on the glycine transporter-1 inhibitor BI 425809 for improving cognitive function in schizophrenia patients.
- His studies highlight significant challenges in conducting respiratory studies, emphasizing the need for specific therapeutic knowledge and skill among clinical research professionals to navigate the complexities involved.
- Additionally, Hake addresses the importance of negotiation skills in clinical research, advocating for thorough preparation and a focus on interests rather than positions to enhance collaboration among stakeholders in the research process.
